Ken Griffin In Mode Ltd. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$15.43 - $19.06 $1.14 Million - $1.4 Million	73,700 Added 39.54%	260,100 $4.4 Million
Q2 2024 Aug 14, 2024	SELL	$17.02 - $21.0 $1.65 Million - $2.04 Million	-97,200 Reduced 34.27%	186,400 $3.4 Million
Q1 2024 May 15, 2024	SELL	$20.45 - $26.49 $7.86 Million - $10.2 Million	-384,500 Reduced 57.55%	283,600 $6.13 Million
Q4 2023 Feb 14, 2024	BUY	$19.02 - $30.13 $6.93 Million - $11 Million	364,300 Added 119.91%	668,100 $14.9 Million
Q3 2023 Nov 14, 2023	BUY	$30.46 - $46.04 $1.89 Million - $2.86 Million	62,200 Added 25.75%	303,800 $9.25 Million
Q2 2023 Aug 14, 2023	SELL	$31.57 - $37.73 $2.78 Million - $3.32 Million	-88,100 Reduced 26.72%	241,600 $9.02 Million
Q1 2023 May 15, 2023	SELL	$29.72 - $41.45 $9.99 Million - $13.9 Million	-336,000 Reduced 50.47%	329,700 $10.5 Million
Q4 2022 Feb 14, 2023	BUY	$30.23 - $38.71 $985,498 - $1.26 Million	32,600 Added 5.15%	665,700 $23.8 Million
Q3 2022 Nov 14, 2022	BUY	$22.51 - $38.27 $7.22 Million - $12.3 Million	320,800 Added 102.72%	633,100 $18.4 Million

295

48.4M

1.81M

1.66M

Ticker INMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,081,104
Market Cap $1.54B
Description
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.